FXR agonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FXR agonist, covering 2016-09-29 to 2016-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients [Phase 2]